268 related articles for article (PubMed ID: 10533821)
1. Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage.
Lozano M; Estebanell E; Cid J; Diaz-Ricart M; Mazzara R; Ordinas A; Escolar G
Transfusion; 1999 Sep; 39(9):951-9. PubMed ID: 10533821
[TBL] [Abstract][Full Text] [Related]
2. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
3. Superior integrin activating capacity and higher adhesion to fibrinogen matrix in buffy coat-derived platelet concentrates (PCs) compared to PRP-PCs.
Beshkar P; Hosseini E; Ghasemzadeh M
Transfus Apher Sci; 2018 Feb; 57(1):76-81. PubMed ID: 29292029
[TBL] [Abstract][Full Text] [Related]
4. Effect of holding buffy coats 4 or 18 hours before preparing pooled filtered PLT concentrates in plasma.
Pérez-Pujol S; Lozano M; Perea D; Mazzara R; Ordinas A; Escolar G
Transfusion; 2004 Feb; 44(2):202-9. PubMed ID: 14962311
[TBL] [Abstract][Full Text] [Related]
5. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods.
Metcalfe P; Williamson LM; Reutelingsperger CP; Swann I; Ouwehand WH; Goodall AH
Br J Haematol; 1997 Jul; 98(1):86-95. PubMed ID: 9233569
[TBL] [Abstract][Full Text] [Related]
6. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
Sandgren P; Hansson M; Gulliksson H; Shanwell A
Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
[TBL] [Abstract][Full Text] [Related]
7. Loss of high-affinity thrombin receptors during platelet concentrate storage impairs the reactivity of platelets to thrombin.
Lozano ML; Rivera J; Gónzález-Conejero R; Moraleda JM; Vicente V
Transfusion; 1997 Apr; 37(4):368-75. PubMed ID: 9111273
[TBL] [Abstract][Full Text] [Related]
8. Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation.
Hechler B; Ohlmann P; Chafey P; Ravanat C; Eckly A; Maurer E; Mangin P; Isola H; Cazenave JP; Gachet C
Transfusion; 2013 Jun; 53(6):1187-200. PubMed ID: 23067365
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methods.
Fijnheer R; Pietersz RN; de Korte D; Gouwerok CW; Dekker WJ; Reesink HW; Roos D
Transfusion; 1990 Sep; 30(7):634-8. PubMed ID: 2144922
[TBL] [Abstract][Full Text] [Related]
10. Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma.
Boeri N; Saleun S; Pelissier E; Saleun JP; Aiach M; Rendu F
Transfusion; 1994 Oct; 34(10):881-6. PubMed ID: 7940660
[TBL] [Abstract][Full Text] [Related]
11. Platelet quality after 15-day storage of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Porretti L; Murphy S
Transfusion; 1992 Jan; 32(1):9-16. PubMed ID: 1731448
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of leukocyte-depleted platelet concentrates obtained by in-line filtration.
Ferrer F; Rivera J; Corral J; González-Conejero R; Vicente V
Vox Sang; 2000; 78(4):235-41. PubMed ID: 10895097
[TBL] [Abstract][Full Text] [Related]
13. Automated preparation of whole blood-derived platelets suspended in two different platelet additive solutions and stored for 7 days.
Cid J; Magnano L; Molina P; Diaz-Ricart M; Martínez N; Maymó RM; Puig L; Lozano M; Escolar G; Galán AM
Transfusion; 2014 Feb; 54(2):426-33. PubMed ID: 23721299
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of platelet concentrates, prepared from pooled buffy coats, stored for 8 days after filtration.
Boomgaard MN; Joustra-Dijkhuis AM; Gouwerok CW; Steneker I; Reesink HW; Loos JA; Pietersz RN; de Korte D
Transfusion; 1994 Apr; 34(4):311-6. PubMed ID: 8178328
[TBL] [Abstract][Full Text] [Related]
15. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
[TBL] [Abstract][Full Text] [Related]
16. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
Skripchenko A; Kurtz J; Moroff G; Wagner SJ
Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
[TBL] [Abstract][Full Text] [Related]
17. [Platelet membrane glycoproteins in thrombocytapheresis and platelet concentrates].
Dittmann J; Riggert J; Wieding JU; Simson G; Köhler M
Beitr Infusionsther Transfusionsmed; 1994; 32():422-7. PubMed ID: 9480137
[TBL] [Abstract][Full Text] [Related]
18. Effects of the addition of second-messenger effectors to platelet concentrates separated from whole-blood donations and stored at 4 degrees C or -80 degrees C.
Lozano M; Escolar G; Mazzara R; Connor J; White JG; DeLecea C; Ordinas A
Transfusion; 2000 May; 40(5):527-34. PubMed ID: 10827254
[TBL] [Abstract][Full Text] [Related]
19. In vitro analysis of platelet concentrates stored in the presence of modulators of 3',5' adenosine monophosphate, and organic anions.
Lozano ML; Rivera J; Bermejo E; Corral J; Pérez E; Vicente V
Transfus Sci; 2000; 22(1-2):3-11. PubMed ID: 10771373
[TBL] [Abstract][Full Text] [Related]
20. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
